FILE- In this April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Shares of Eli Lilly and Co. jumped early Thursday, June 24, 2021, after the drugmaker said it will seek approval for its potential Alzheimer’s treatment later this year. (AP Photo/Darron Cummings, File)
Lilly to seek FDA approval for potential Alzheimer's drug
Nov 16, 2021 06:49:31 PM
Related news
-
House passes $35-a-month insulin cap as Dems seek wider bill -
Strained US hospitals seek foreign nurses amid visa windfall
-
Washington seeks over $38 billion from opioid distributors
-
Regulators seek to suspend Trump rule on railway natural gas
-
German agency suspends approval process for Russia pipeline
-
EU ministers seek to cement trade ties with Biden team
Top Stories
-
Chinese firms willing to invest more in EU if business environme Nov 06, 2020
-
Guangzhou's exhibition industry recovers from COVID-19 Nov 13, 2020
-
Tariffs for imports to be lowered next year Dec 27, 2020
-
China overtakes U.S. as world's top destination for FDI in 2020: Jan 26, 2021
-
Chinese vice premier stresses achieving higher-quality employment Feb 24, 2021
